{
    "code": 0,
    "data": [
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Clarification On Price Movement",
            "news_body": "Clarification on Price Movement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17698270-77aa-4649-9a37-81c6487ac118.pdf",
            "news_date": "2026-02-03 19:09:04"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Biofil Chemicals & Pharmaceuticals Ltd",
            "news_body": "The Exchange has sought clarification from Biofil Chemicals & Pharmaceuticals Ltd on February 3 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2026-02-03 18:17:00"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Meeting Of Board Of The Directors (Serial No. 07/2025-26) Of The Company Scheduled To Be Held On Friday 13Th February 2026 .",
            "news_body": "Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve 1. the Un-Audited Financial Results of the Company for the Quarter and Nine Month ended on 31st December 2025 along with Limited Review Report thereon.\r\n2. To consider other routine matters with the permission of the chair.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32f163bc-b121-4cd9-a988-29e08500a6c6.pdf",
            "news_date": "2026-02-03 15:19:10"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 for the quarter ended on 31st December2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec83611e-8ee1-4cfb-a10a-dff07c454ccc.pdf",
            "news_date": "2026-01-02 13:12:52"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of Trading window with effect from Thursday 01st January 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70f37bae-d65d-44c1-878a-ab4d3a43265f.pdf",
            "news_date": "2025-12-23 18:18:43"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Receipt Of Fine From BSE Limited.",
            "news_body": "Receipt of Fine from BSE Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8cf65bd-f08c-4bca-8cd3-1f0a81503496.pdf",
            "news_date": "2025-12-03 19:46:34"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Receipt of Fine from National Stock Exchange.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5073e72-75ab-403c-824e-64d0e3509723.pdf",
            "news_date": "2025-11-26 19:16:01"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Submission of Publication of Un-audited Financial Result in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirement) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=82edce5e-87f4-402f-8e62-10ef886f2493.pdf",
            "news_date": "2025-11-15 13:48:04"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for To Review Consider And Approve The Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2025 Along With Limited Review Report",
            "news_body": "To review consider and approve the Standalone Unaudited Financial Results for the quarter and half year ended on 30th September 2025 along with Limited Review Report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15885994-981e-4410-9d26-01e063e8ee87.pdf",
            "news_date": "2025-11-13 19:39:42"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "To Review Consider And Approve The Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2025 Along With Limited Review Report.",
            "news_body": "To review consider and approve the Standalone Unaudited  Financial Results for the quarter and half year ended on 30th September 2025 along with Limited Review Report",
            "news_id": "3ade2adc-b49e-4e93-97f8-27c3126c7f9f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8064f5b-d82a-4a8b-802b-f158d5cf19f4.pdf",
            "news_date": "2025-11-13 19:15:18",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "To Review Consider And Approve The Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2025 Along With Limited Review Report.",
            "news_body": "To review consider and approve the Standalone Unaudited  Financial Results for the quarter and half year ended on 30th September 2025 along with Limited Review Report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8064f5b-d82a-4a8b-802b-f158d5cf19f4.pdf",
            "news_date": "2025-11-13 19:15:18"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September 2025.",
            "news_body": "Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve To consider and approve the Unaudited Financial results of the Company for the Quarter and half year ended on 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1389260e-46f8-484f-9e94-989320274d7d.pdf",
            "news_date": "2025-11-07 16:20:15"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 for the quarter ended on 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a25fb19-cdd4-4953-a840-5c33007f3556.pdf",
            "news_date": "2025-10-04 13:07:03"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of Trading Window with effect from Wednesday 01st October 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81cad10e-a76b-48af-b817-d36e967bbe18.pdf",
            "news_date": "2025-09-29 19:15:45"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Continuous Disclosure of following material events or information for which disclosure as required under sub-clause 7 of Part A Para A of Schedule III :\r\n1. Confirmation of appointment of Joshi Sahay and Company Practicing Company Secretary as Secretarial Auditor of the company and fix their remuneration.\r\n2. Confirmation of re-appointment of Mr. Ashok Kumar Ramawat  (DIN: 08818263) as Independent Director for second term of 5 years.\r\n3. Confirmation of re-appointment of Mr. Satish Behor (DIN: 09220291) as independent director for second term of 5 years.\r\n4. Confirmation of change in Designation of Mr. Ketan Shah (DIN: 08818212) from Whole time director to Chairman and Managing Director\r\n5. Confirmation of Appointment of Mr. Smitesh Shah (DIN: 00326182) as promoter Non-executive Non- Independent Director of the company.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=363dfbc0-f8e7-459e-998b-af7c084e7dd4.pdf",
            "news_date": "2025-09-29 17:20:54"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Scrutinizer Report With Voting Result",
            "news_body": "Scrutinizer report with voting result",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fc87991-724e-4b83-a777-df0648c35a60.pdf",
            "news_date": "2025-09-29 15:35:44"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Scrutinizer Report With Voting Result",
            "news_body": "Scrutinizer report with voting result",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb7a1c5c-2d59-4124-ae7f-c2a397a462ef.pdf",
            "news_date": "2025-09-29 15:24:38"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Summary Of Proceedings Of 40Th Annual General Meeting Of The Company Held On Saturday 27Th September 2025 Pursuant To Regulation 30 Read With Para A Of Part A Of Schedule III Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015.",
            "news_body": "Summary of Proceeding of 40th Annual General Meeting of the Company held on Saturday 27th September 2025 .",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=088ad912-0d73-4199-97e4-a7d16d5d2ae2.pdf",
            "news_date": "2025-09-27 20:01:58"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Submission of voting results of postal ballot and report of Scrutinizer",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f37a135-e928-4400-a696-99d02d5d1929.pdf",
            "news_date": "2025-09-15 17:50:54"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Pursuant to Regulation 30 44 and 47 of SEBI(LODR) Regulations 2015 and in compliance with Section 108 of the Companies Act 2013 read with rule 20 of Companies (Management and Administration) Rules 2014 we enclosed herewith extract of newspaper advertisement published on 31st August2025 in Free Press and Choutha Sansar Indore Edition.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9841ee51-e526-49d5-970d-3175c38c5175.pdf",
            "news_date": "2025-09-01 12:15:04"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Information Regarding E-Voting For 40Th Annual General Meeting",
            "news_body": "Information under Regulation 44 of SEBI (LODR) Regulation 2015 and Section 108 of Companies Act 2013 regarding Voting through Electronic mode for the 40th Annual General Meeting to be held on Saturday 27th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca72d899-cc74-429b-a946-df6050920e76.pdf",
            "news_date": "2025-08-29 18:45:28"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation For Dispatch Of Letter To Those Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository Participants",
            "news_body": "Intimation for Dispatch of Letter to those Shareholders whose e-mail addresses are not registered with company/ registrar & transfer agent/ depository participants",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd21dd20-7b36-4863-b7ff-4a86239ce4d1.pdf",
            "news_date": "2025-08-29 18:40:52"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Submission of Annual Report for the Financial Year 2024-25 pursuant to Regulation 34 of SEBI (Listing Obligation and Disclosure Requirement) Regulation 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b785185-5106-4c14-b55f-365ae1ab49b1.pdf",
            "news_date": "2025-08-29 18:36:46"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Submission Of Notice Of Convening 40Th AGM Of The Company.",
            "news_body": "Submission of Notice of 40th AGM scheduled to be held on Saturday 27th September 2025 at 03:00 P.M. (IST) through video conference (VC)/Other audio visual means (OAVM)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=587e93ad-c562-4d41-8709-7312f32f48d4.pdf",
            "news_date": "2025-08-29 18:28:48"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Appointment of Mr. Smitesh Shah (DIN: 00326182) as an Additional Director under the category of Promoter Non- Executive Non Independent Director of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6bf17eb7-c29e-4677-a59f-973f5751dab3.pdf",
            "news_date": "2025-08-23 18:26:40"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of Notice of AGM through Video Conferencing (VC)/other Audio Visual Means (OAVM)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6358dde8-7287-4b66-b7f3-867dd729f8cd.pdf",
            "news_date": "2025-08-22 12:54:23"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Submission of publication of Un-audited financial results in the Newspaper pursuant to Regulation 47 of SEBI(Listing Obligations and Disclosure Requirement) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a24ca91-7cbd-44c1-8674-e1705629b71b.pdf",
            "news_date": "2025-08-14 12:36:13"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Chairman",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=070c59da-4169-494c-a343-9b1714fdf133.pdf",
            "news_date": "2025-08-12 20:23:37"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Managing Director",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ad9de3c-625f-4bc8-bfe9-e10efcf1ca88.pdf",
            "news_date": "2025-08-12 20:22:02"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Secretarial Auditor",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc21f9a9-e31f-4811-b755-b939ca08bdd5.pdf",
            "news_date": "2025-08-12 20:20:29"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Re-appointment of Independent Director.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7eb4a061-56df-42e6-b1db-29be41cf3ed8.pdf",
            "news_date": "2025-08-12 20:17:44"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Registered Office Address",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Registered Office Address",
            "news_body": "Change in Registered office within City",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef084c6a-d92d-4460-b20a-6c47bc9df6f5.pdf",
            "news_date": "2025-08-12 20:15:18"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended 30Th June 2025",
            "news_body": "Un-Audited Financial Results for the quarter ended 30th June 2025",
            "news_id": "decbc563-5d51-4411-aac1-5d65e13bd4dd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fddc35e9-0f9d-4501-a764-1ab2c5aff860.pdf",
            "news_date": "2025-08-12 19:33:28",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended 30Th June 2025",
            "news_body": "Un-Audited Financial Results for the quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fddc35e9-0f9d-4501-a764-1ab2c5aff860.pdf",
            "news_date": "2025-08-12 19:33:28"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 12Th August 2025 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirement) Regulations 2015",
            "news_body": "Outcome of Board Meeting held on Tuesday 12th August 2025 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirement) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70462623-10c6-4820-bbb7-95712494fb98.pdf",
            "news_date": "2025-08-12 19:25:40"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication advertisement of dispatch of postal ballot notice and remote e voting information.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b983e1c3-96c4-40e7-a33e-11e5534f437a.pdf",
            "news_date": "2025-08-12 14:51:44"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Notice of Postal Ballot",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4286fc1f-3444-4c26-8652-e835eb4c5ea7.pdf",
            "news_date": "2025-08-08 16:29:07"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation For Meeting Of Board Of Directors Of The Company Schedule To Be Held On Tuesday 12Th August 2025 Pursuant To Regulation 29 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) ",
            "news_body": "Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve 1.To consider and approve the Un-Audited Financial Results of the Company for the first Quarter ended on 30th June 2025 along with Limited Review Report thereon.\r\n2. To consider other routine matters with the permission of the chair.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b792f5c3-f4a1-42d8-972f-da2e651510b4.pdf",
            "news_date": "2025-08-04 19:39:42"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Continuous Disclosure Under Sub-Para 1 Of Para A Of Part A Of Schedule III Of The SEBI (LODR) Regulations 2015 Read With SEBI Circular SEBI/HO/CFD/CFD-Pod-1/P/CIR/2023/123 Dated 13Th July 2023",
            "news_body": "Sell transfer or otherwise dispose the lease hold right of Industrial land subject to approval of members.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=96d348d2-54f6-4565-8493-c1cbfddea0d0.pdf",
            "news_date": "2025-08-04 18:47:30"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 04Th August 2025 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Outcome of Board Meeting held on Monday 04th August 2025 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=827797a7-ea7a-4236-aa97-cf34f1149888.pdf",
            "news_date": "2025-08-04 18:35:58"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 for the quarter ended on 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc414091-480d-4c6b-bf5d-e69785487988.pdf",
            "news_date": "2025-07-03 13:35:33"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "The Trading window for dealing in the securities of the Company shall remain closed for all Designated Persons their immediate relatives and connected persons (as defined in the Code) w.e.f. Tuesday July 01 2025 for the purpose of consideration of Un-Audited Financial Results for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40d343cc-b345-4eac-bdb3-87d4895ef23b.pdf",
            "news_date": "2025-06-26 15:10:29"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation To The Shareholders Holding Shares In Physical Mode For Mandatory Furnishing Of PAN KYC Details Bank Account Details Nomination And Other Details.",
            "news_body": "The Company hereby submit drafts intimation letter sent to holders of physical shares of the company for updating PAN KYC Nomination and other details in accordance with applicable SEBI circulars in terms of provisions of Reg.30 of SEBI (LODR) Regulations 2015 as amended from time to time.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a05a9b93-ad0c-4ff1-aa28-ab8f25b8857a.pdf",
            "news_date": "2025-06-12 15:21:15"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Submission of Publication of Financial Results in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirement) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8041f1a9-de83-4475-9d6a-7ca39769b73d.pdf",
            "news_date": "2025-05-31 15:01:12"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Result For The Financial Year Ended 31.03.2025",
            "news_body": "Audited Financial Result for the Financial Year ended 31.03.2025",
            "news_id": "f7b8f8ee-0cb1-4820-bc16-87652bc4174a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1cddcdc-687e-4188-a72a-e3c7f83feaa3.pdf",
            "news_date": "2025-05-30 18:36:25",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Audited Financial Result For The Financial Year Ended 31.03.2025",
            "news_body": "Audited Financial Result for the Financial Year ended 31.03.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1cddcdc-687e-4188-a72a-e3c7f83feaa3.pdf",
            "news_date": "2025-05-30 18:36:25"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 30Th May 2025 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
            "news_body": "Outcome of Board Meeting held on Friday 30th May 2025 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14e46fd7-b207-49d7-b72a-927f919e54b5.pdf",
            "news_date": "2025-05-30 18:29:27"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Submission of Annual Secretarial Compliance Report for the financial year ended 31st March 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=996aa82a-701c-4915-a726-84177cf15468.pdf",
            "news_date": "2025-05-27 12:06:28"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation For Meeting Of Board Of The Directors (Serial No.02/2025-26) Of The Company Scheduled To Be Held On Friday 30Th May 2025.",
            "news_body": "Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve Intimation for meeting of Board of the Directors (Serial No.02/2025-26) of the Company scheduled to be held on Friday 30th May 2025 pursuant to the Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b521bd0-c80f-40cf-8c5e-f51fd2ce623a.pdf",
            "news_date": "2025-05-22 15:27:01"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Compliance",
            "descriptor": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ",
            "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
            "news_body": "  <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Biofil Chemicals & Pharmaceuticals Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24233MP1985PLC002709</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table>  <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Apoorv Jain <br/>  Designation: Company Secretary and Compliance Officer <br/> EmailId: bcplcompliance@gmail.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Pavan Singh Rajput <br/> Designation: Chief Financial Officer <br/> EmailId: pawan90rajkam@gmail.com</div> </div> <div> <br/> Date: 22/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38192407-3ba0-4c2b-8ee6-0fad9c052d12.pdf",
            "news_date": "2025-04-22 14:56:37"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (5) Of SEBI (LODR) Regulation  2015",
            "news_body": "Appointment of Mr. Apoorv Jain ACS (71739) as Company Secretary and Compliance Officer of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75bb8060-de9b-46d0-b981-71a6b9a3152e.pdf",
            "news_date": "2025-04-19 15:07:53"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Mr. Apoorv Jain (ACS) 71739 as a Company Secretary and Compliance Officer of the company w.e.f. 19th April 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4572b0e2-e801-421f-9bcb-cfe5569588eb.pdf",
            "news_date": "2025-04-19 14:55:51"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Appointment of Company Secretary / Compliance Officer",
            "caption": "Appointment of Company Secretary and Compliance Officer",
            "news_body": "Appointment of Mr. Apoorv Jain as Company Secretary (KMP) and Compliance Officer of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0bb3736-cff0-4bdf-a879-b4afc338abd8.pdf",
            "news_date": "2025-04-19 14:49:33"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate for Regulation 74(5) of Securities and Exchange Board of India(Depository Participants) Regulation 2018 for the quarter end 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c208705-d76a-40c6-b785-c3f689d2c14b.pdf",
            "news_date": "2025-04-05 11:38:00"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of trading window period for quarter and year ended 31.03.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2dbfc507-8523-4cfc-b8a6-f1a3c17b1e29.pdf",
            "news_date": "2025-03-25 14:41:49"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Confirmation of appointment of Meet Shah DIN 06578351 from Additional director to director undet the catagory of non executive non independent director",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=460e4f7a-e9bf-424d-ae62-8a8aca5cfedc.pdf",
            "news_date": "2025-03-22 16:08:44"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Submission of voting results of postal ballot and report of scrutinizer",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5becb85b-550e-48bf-b3b1-bb4a6afffe65.pdf",
            "news_date": "2025-03-22 14:50:56"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Demise",
            "caption": "Announcement under Regulation 30 (LODR)-Demise",
            "news_body": "Disclosure under Regulation 30 read with Part A of Schedule III of the SEBI (LODR) Regulations 2015- Intimation of Sudden demise of Mr. Ramesh Shah (DIN: 00028819) Chairman and Managing Director of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c3278c6-6d86-465f-b9af-27b542bcfe34.pdf",
            "news_date": "2025-03-11 17:22:19"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Disclosure under Regulation 30 read with Part A of Schedule III of the SEBI (LODR) Regulations 2015- Intimation of Sudden demise of Mr. Ramesh Shah (DIN: 00028819) Chairman and Managing Director of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04f0c2e3-6cee-4db7-a86c-707e50c54d37.pdf",
            "news_date": "2025-03-11 17:19:31"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Postal Ballot",
            "caption": "Revise Calender Of Events For Postal Ballot",
            "news_body": "Revise Calender of events for postal ballot",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6cd6ba6-9202-4f74-a3a4-6bfb4497023e.pdf",
            "news_date": "2025-02-19 15:03:03"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication advertisement of dispatch of postal ballot notice and remote evoting information",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54f46461-804d-4498-b627-52f4fe6e4ca2.pdf",
            "news_date": "2025-02-18 12:37:46"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Postal Ballot",
            "caption": "Calender Of Events Of Postal Ballot",
            "news_body": "Calender of events of postal ballot",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59184037-fcc6-4023-ae96-0f8ee5d648bd.pdf",
            "news_date": "2025-02-17 19:18:14"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Notice of postal ballot process through electronic voting Machanism",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5caec6d7-02bd-4222-84b8-60c8ec7441b1.pdf",
            "news_date": "2025-02-17 18:50:38"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication for advertisement published for unaudited financial results for quarter ended Dec 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d335c511-8064-448c-9389-682ba1da3dbe.pdf",
            "news_date": "2025-02-13 15:26:29"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Integrated financial for quarter ended dec 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2eae2f1d-cf97-46b1-bab6-43b0d62d26c6.pdf",
            "news_date": "2025-02-11 17:41:22"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Continuous Disclosure Purusant To Para A Part A Of Schedule III",
            "news_body": "Continuous disclosure pursuant to para A of Part A of schedule III",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cd0404f-1a5a-41b3-aa93-f820d55f1a58.pdf",
            "news_date": "2025-02-11 17:39:08"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Continuous Disclosure Purusant To Para A Part A Of Schedule III",
            "news_body": "Continuous dislcosure pursuent to para A part A of Schedule III",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e31fd5f7-04f1-4843-9600-937b4a6fb8b6.pdf",
            "news_date": "2025-02-11 17:38:03"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un Audited Financial Result For Quarted Dec 2024",
            "news_body": "Unaudited financial result for quarter ended Dec 2024",
            "news_id": "43620431-4701-493b-96a5-5349667c33df",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee82a8f8-fe8d-40f0-bc7d-12a02d04e8d2.pdf",
            "news_date": "2025-02-11 17:30:05",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Un Audited Financial Result For Quarted Dec 2024",
            "news_body": "Unaudited financial result for quarter ended Dec 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee82a8f8-fe8d-40f0-bc7d-12a02d04e8d2.pdf",
            "news_date": "2025-02-11 17:30:05"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 11.02.2025",
            "news_body": "Outcome of Board meeting held on 11.02.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b805ca0a-1028-45e9-b2dc-2222157297fc.pdf",
            "news_date": "2025-02-11 17:27:42"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation For Board Meeting To Be Held To Consider Unaudited Financial Results For The Quarter Ended 31St December 2024 Alongwith Other Routine Businesses.",
            "news_body": "BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve Intimation for Board Meeting to be held to consider Unaudited Financial Results for the Quarter ended 31st December 2024 alongwith other routine businesses.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bae871b6-fb18-4a9a-b6a8-b364bdba4424.pdf",
            "news_date": "2025-02-04 16:24:01"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Reg 74(5) for Dec 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ec6d9c6-27ac-4ace-9b3a-123f03be089d.pdf",
            "news_date": "2025-01-07 13:26:36"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Appointment of Mr. Meet Shah (DIN: 06578351) as additional director under the catagory of promoter non executive director of the company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bab9f2a6-0538-491b-aca4-96c9de322bce.pdf",
            "news_date": "2024-12-30 17:25:48"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading window for Dec 2024 quarter",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40c038dd-0f36-459d-a361-5687ce54d04b.pdf",
            "news_date": "2024-12-23 15:37:57"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Company Update",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Resignation of Company Secretary and Compliance officer (Senior Management) of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7561b92-addd-4eeb-9a0c-8c6a1fd6b826.pdf",
            "news_date": "2024-12-16 19:45:20"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Company Update",
            "descriptor": "Resignation of Company Secretary / Compliance Officer",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
            "news_body": "Resignation of company secretary and compliance officer of the company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9c4c9fc-d330-45d1-921f-957e0faf7003.pdf",
            "news_date": "2024-12-16 19:20:47"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Company Update",
            "descriptor": "Resignation of Director",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
            "news_body": "Mr. Romil Shah (DIN:00326110) has tendered his resignation from post of Non Executive Non independent Director of the company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1748917-5ae3-4309-882b-974fe34c9652.pdf",
            "news_date": "2024-11-27 19:44:15"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication for extracts of Unaudited financial results for Sep 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bab50d1d-9c3b-4f36-a527-0439deb4ea1e.pdf",
            "news_date": "2024-11-15 19:27:01"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "OUTCOME OF BOARD MEETING HELD ON 14TH NOVEMBER, 2024 ALONGWITH FINANCIAL RESULTS FOR QUARTER AND HALF YEAR ENDED 30 SEPTEMBER 2024",
            "news_body": "OUTCOME OF BOARD MEETING ALONGWITH FINANCIAL RESULTS",
            "news_id": "5ef4f552-92ce-4760-996c-e11fb87bf60e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9c05a38-c767-42c8-a981-e638558f7204.pdf",
            "news_date": "2024-11-14 19:17:28",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "OUTCOME OF BOARD MEETING HELD ON 14TH NOVEMBER, 2024 ALONGWITH FINANCIAL RESULTS FOR QUARTER AND HALF YEAR ENDED 30 SEPTEMBER 2024",
            "news_body": "OUTCOME OF BOARD MEETING ALONGWITH FINANCIAL RESULTS",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9c05a38-c767-42c8-a981-e638558f7204.pdf",
            "news_date": "2024-11-14 19:17:28"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 14TH NOVEMBER, 2024",
            "news_body": "OUTCOME OF BOARD MEETING HELD ON 14TH NOVEMBER, 2024 PURSUANT TO REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4673810-b598-499b-b45b-4c1b752dd5ec.pdf",
            "news_date": "2024-11-14 19:14:07"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation For Meeting Of Board Of Directors Scheduled To Be Held On Thursday, 14Th November, 2024",
            "news_body": "BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve Intimation for meeting of Board of Directors scheduled to be held on Thursday, 14th November, 2024 to consider and approve un-audited Financial Results for the quarter as well as half year ended on 30th September, 2024 and other routine businesses",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e021ca2-deac-4d53-850b-f1edba7b0da4.pdf",
            "news_date": "2024-11-07 18:15:11"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Certificate under regulatin 74(5) of SEBI (Depositories and participants) regulations 2018 for quarter ended Sep 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=138f4ee5-6777-4a00-b91a-230e20c8247a.pdf",
            "news_date": "2024-10-09 19:17:59"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Information regarding issue of letter of confirmation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=acdd2fbf-5b3f-410f-92ee-a8920bf74cdc.pdf",
            "news_date": "2024-10-09 19:13:25"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizer''s Report",
            "news_body": "Combined Scrutinizer report alongwith voting results for AGM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a95d4ba3-befe-4d75-9d7e-3c87db5a7153.pdf",
            "news_date": "2024-10-01 20:56:12"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Summary of Proceeding of 39th AGM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6b4e3e0-ebd5-4605-8ef4-b2da8a914dae.pdf",
            "news_date": "2024-09-30 19:51:46"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation for Closure of Trading Window for quarter ended September, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f75932b7-bce0-4995-8842-e1cff0650b1f.pdf",
            "news_date": "2024-09-26 18:09:06"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Intimation under Regulation 39(3) for stop transfer and issue of duplicate share certificate",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fecb03df-8e04-4826-a57b-cceef7a3fa59.pdf",
            "news_date": "2024-09-16 18:03:14"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Announcements Under Regulation 30(5) Of SEBI (LODR), Regulations, 2015",
            "news_body": "Details of persons authorized for the purpose of determining the materiality of event or information and have been authorized for making the disclosures to the Stock Exchanges",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6117bc2-2320-40f5-aca5-84f5ae738b99.pdf",
            "news_date": "2024-09-14 17:37:00"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Company Update",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Ms. Anisha Mangal (ACS) 70128 as a Company Secretary and Compliance officer of the Company w.e.f. 14th September, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2fa180f3-eaa8-43dc-b34a-1579b985cc7c.pdf",
            "news_date": "2024-09-14 17:29:30"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Company Update",
            "descriptor": "Appointment of Company Secretary / Compliance Officer",
            "caption": "Appointment of Company Secretary and Compliance Officer",
            "news_body": "Appointment of Ms. Anisha Mangal (ACS: 70128) as a Company Secretary and Compliance officer of the Company w.e.f. 14th September, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a333576a-11b4-4883-87a4-461cf7596a63.pdf",
            "news_date": "2024-09-14 17:27:06"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "News paper publication for Information of dispatch of Notice of AGM and Annual report to the members",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c17298d-265c-4956-9719-e4dc278992be.pdf",
            "news_date": "2024-09-05 20:04:55"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Inegrated Annual report of Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98174f63-b674-457e-a61b-471346b01549.pdf",
            "news_date": "2024-09-04 18:09:40"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Information Under Regulation 44 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 And Section 108 Of The Companies Act, 2013 Regarding Voting Through Electronic Mode For The 39Th Annual General Meeting To Be Held On Monday, 30Th September, 2024.",
            "news_body": "Information under Regulation 44 of SEBI (LODR) regulation 2015 and section 108 of Companies Act, 2013 for evoting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6894000c-3e21-45ac-99d5-fd045603e2bf.pdf",
            "news_date": "2024-09-04 18:02:58"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Corp. Action",
            "descriptor": "Book Closure",
            "caption": "Intimation Of Book Closure For The Purpose Of 39Th AGM",
            "news_body": "Intimation of Book Closure for the purpose of 39th AGM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb7eef14-86c5-4c99-8254-6e8cae589f2f.pdf",
            "news_date": "2024-09-04 18:00:40"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Notice Of 39Th AGM",
            "news_body": "Notice of 39th AGM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33659235-8543-49b9-a058-b7139e5b743d.pdf",
            "news_date": "2024-09-04 17:58:57"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication regarding intimation of AGM of the COmpany scheduled to be held on 30th September 2024 and informing shareholders manner of registration of email",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc17883d-ddea-46fe-953d-3b9579da79c2.pdf",
            "news_date": "2024-08-30 15:17:15"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "A copy of extracts of an unaudited results for the quarter ended 30th June, 2024 published in Newspapers dated 14th August, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3392f430-5a96-44ea-b91e-3d6c69f50d78.pdf",
            "news_date": "2024-08-14 12:22:47"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Continuous Disclosure Under Sub-Para 1 Of Para A Of Part A Of Schedule III Of The SEBI (LODR) Regulations, 2015 Read With SEBI Circular SEBI/HO/CFD/CFD-Pod-1/P/CIR/2023/123 Dated 13Th July, 2023",
            "news_body": "Entering in to agreement for sale transfer otherwise dispotal of undertaking subject to approval of members",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3618398-7e7c-4149-84fb-8f3273803b33.pdf",
            "news_date": "2024-08-13 18:40:27"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results Of The Company For The Quarter Ended On 30Th June, 2024 Along With Limited Review Report Thereon",
            "news_body": "Un-audited financial results for the quarter ended 30th June 2024",
            "news_id": "32030940-96ae-451f-a74c-6eb224b8f5d9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1583fef3-4b9d-4be0-9d3f-d3a3064125d5.pdf",
            "news_date": "2024-08-13 18:33:41",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Un-Audited Financial Results Of The Company For The Quarter Ended On 30Th June, 2024 Along With Limited Review Report Thereon",
            "news_body": "Un-audited financial results for the quarter ended 30th June 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1583fef3-4b9d-4be0-9d3f-d3a3064125d5.pdf",
            "news_date": "2024-08-13 18:33:41"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 13Th August, 2024 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Outcome of Board Meeting held on Tuesday 13th August, 2024 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e226fb1-4756-4a52-bbf1-688b89d93ac5.pdf",
            "news_date": "2024-08-13 18:30:30"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation For Meeting Of Board Of The Directors To Be Held On Tuesday, 13Th August, 2024 Pursuant To The Regulation 29 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 ,inter alia, to consider and approve Intimation for meeting of Board of the Directors to be held on Tuesday, 13th August, 2024 pursuant to the Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1a6a26f-7868-4bdf-98f0-602cde5343c3.pdf",
            "news_date": "2024-08-08 17:42:11"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Certificate of Compliance under Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018 for the quarter ended 30th June, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c4ae33ec-d44e-49e6-99b9-40fc80f1deb1.pdf",
            "news_date": "2024-07-10 16:15:28"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Company Update",
            "descriptor": "Resignation of Company Secretary / Compliance Officer",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
            "news_body": "Pursuant to Regulation 30 of the SEBI (LODR), Regulations, 2015, we wish to inform that Ms. Shweta Verma has tendered her resignation vide her resignation letter dated 03.07.2024 from the post of Company Secretary and Compliance Officer of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aac9b9f0-2b2c-4efe-b971-a59d8b155ec2.pdf",
            "news_date": "2024-07-03 16:53:48"
        },
        {
            "co_code": 3284,
            "bse_code": 524396,
            "isin": "INE829A01014",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "The trading window for dealing in securities of the Company shall remain closed for all the Designated Persons, their immediate relatives and connected persons (as defined in the code) w.e.f. Monday, July, 01, 2024 for the purpose of Consideration of Un-Audited Financial Results for the quarter ended June 30, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f8c8ae8-ce0e-467c-ac08-2b64fe35f4ce.pdf",
            "news_date": "2024-06-27 13:15:16"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Results For Quarter And Year Ended 31.03.2024",
            "news_body": "Audited Results for Quarter and Year Ended 31.03.2024.",
            "news_id": "b1c5c1c6-440a-4504-92db-4ca0c2274a41",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7656dcca-23d1-4fbf-a17c-b14ad6105854.pdf",
            "news_date": "2024-05-30 18:48:18",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Un-Audited Financial Results Of The Company For The Quarter As Well As Nine Months Ended On 31St December, 2023 Along With Segment Results And Limited Review Report In Terms Of Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to regulation 33 of SEBI (LODR), Regulations, 2015, we are hereby enclosing un-audited financial results for the quarter as well as nine months ended 31st December, 2023 duly approved by the board of directors at its meeting held today i.e. 06th February, 2024 together with segment results and limited review report thereon. (Copy of Unaudited financial results along with limited review report is enclosed with this letter in searchable mode.)",
            "news_id": "4cc6f80e-05d0-4d38-8c68-8452dae48781",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c72fcbca-eb71-48a8-9399-2db1533f5419.pdf",
            "news_date": "2024-02-06 20:47:09",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Un-Audited Financial Results Of The Company For The Quarter As Well As Half Year Ended On 30Th September, 2023 Along With Segment Results, Statement Of Assets And Liabilities And Cash Flow Statement With Limited Review Report In Terms Of Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Submission of Un-audited Financial Results and limited review report as per regulation 33 of SEBI (LODR) Regulations, 2015 for the Quarter and half year ended 30th September, 2023.",
            "news_id": "84fa294d-af5e-4c55-a0fd-e2272c5f99d8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4405c9a-6f77-45f2-9240-f3cb14b346da.pdf",
            "news_date": "2023-11-09 19:33:49",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Un-Audited Financial Results Of The Company For The Quarter Ended 30Th June, 2023 And Limited Review Report As Per Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Submission of Un-Audited Financial Results of the Company for the Quarter ended 30th June, 2023 and Limited Review Report as per Regulation 33 of SEBI  (LODR) Regulations, 2015",
            "news_id": "d57f195b-7f67-4bb7-8e92-47a6a79a8757",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbb4ecac-cd52-4333-94fd-4f05ea6e9e5c.pdf",
            "news_date": "2023-08-14 18:12:36",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Audited Financial Results For The Quarter As Well As Year Ended 31St March, 2023 In Terms Of Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are here enclosing the Audited Financial Results for the quarter as well as year ended 31st March, 2023 duly approved by the Board of Directors at its meeting held today i.e. Tuesday, 30th May, 2023 together with Audit Report thereon, Statement of assets and liabilities, Cash Flow Statement & declaration by the Managing Director of Company pursuant to second proviso of Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
            "news_id": "33e05b92-6a97-467f-9d83-5aaa2119e723",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b236e5b-4b5c-4c3d-86ab-410a106b6d74.pdf",
            "news_date": "2023-05-30 18:54:44",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Unaudited Financial Results For Quarter & Nine Months Ended 31 Dec 2022.",
            "news_body": "In compliance with Regulation 33 of SEBI (LODR) Regulations, 2015, the Company hereby submits Standalone Un-audited Financial Results for the Quarter as well as Nine Months ended December 31, 2022 duly approved by the Board of Directors of the Company at its meeting held on Tuesday, 14th February, 2023 together with Limited Review Reports thereon.<BR>",
            "news_id": "67565077-715c-41a1-8a89-4f4b1af29b4e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ebfd4328-d2f8-4317-91f7-86d267f2c048.pdf",
            "news_date": "2023-02-14 17:23:04",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended On 30Th September , 2022",
            "news_body": "Pursuant to Regulation 23(9) SEBI (Listing Obligations and Disclosure Requirements)Regulations,2015, please find enclosed herewith the Disclosure of Related party Transactions of the Company for the half year ended 30th September , 2022",
            "news_id": "11f9f403-4504-4fa4-9b57-81b6747707ba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea436d8a-e62e-42bb-9f04-7abc101861c8.pdf",
            "news_date": "2022-11-28 18:35:26",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Period Ended On 30Th September 2022",
            "news_body": "<BR> With reference to the above captioned subject, we would like to inform that Board of Directors of the Company in their meeting (Serial Number 03/2022-23) held on today, approved of the Un-audited Financial Results of the Company for the Quarter and Half year ended on 30th September, 2022 with Segment results, Statement of Assets and Liabilities, Cash Flow Statement and Limited Review Report thereon<BR>",
            "news_id": "157024e9-758e-425e-ad5b-ff127c3f2ecd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cdf15774-853d-42e7-8c36-15e4e5195b99.pdf",
            "news_date": "2022-11-14 19:48:01",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Un-Audited Financial Result And Limited Review Report Thereon For The Quarter Ended On 30Th June, 2022.   <BR> <BR>",
            "news_body": "This is in continuation of our letter dated 2nd August, 2022 regarding information of Board Meeting for consideration and approval of un-audited Financial Results for the quarter ended on 30th June, 2022.<BR> <BR> Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are pleased to submit the Un-audited Financial Results together with Limited Review Report thereon for the quarter ended 30th June 2022 duly approved by the Board of Directors of the Company at its meeting held today i.e. on Tuesday, 9th August, 2022 at the Registered office of the Company. Copy of Unaudited Financial Results along with Limited Review Report is enclosed with this letter (searchable PDF mode).<BR> <BR> Further, copy of Un-Audited Financial Statements shall also be submitted in XBRL mode within 24 hours from the conclusion of Board Meeting.  <BR> <BR> <BR> <BR>",
            "news_id": "98dde565-9a65-4372-9e0d-5b6f513c9820",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e68a78d-44bd-4e93-a61e-d2c9fe02efc3.pdf",
            "news_date": "2022-08-09 17:57:36",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure  Of Related Party Transactions  For The Half Year Ended Oon 31St March , 2022",
            "news_body": "Pursuant to Regulation 23(9) SEBI(Listing Obligations and Disclosure Requirements) Regulations,2015, please find enclosed herewith the Disclosure  of Related party Transactions of the Company  for the half year ended 31st March , 2022You are requested to please take on record the above said document for your reference and further needful.",
            "news_id": "6acb7781-aafe-426d-af14-29c352e1ceef",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43dd4d76-0409-489a-9ab5-646040b7565e.pdf",
            "news_date": "2022-06-10 17:47:17",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure  Of Related Party Transactions  For The Half Year Ended Oon 31St March , 2022",
            "news_body": "Pursuant to Regulation 23(9) SEBI(Listing Obligations and Disclosure Requirements) Regulations,2015, please find enclosed herewith the Disclosure  of Related party Transactions of the Company  for the half year ended 31st March , 2022You are requested to please take on record the above said document for your reference and further needful.",
            "news_id": "216f7d12-fa14-4368-af3c-d5815df81982",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83f3fcb1-c73f-44a7-adfa-a47f5a1a1b34.pdf",
            "news_date": "2022-06-10 17:46:14",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure  Of Related Party Transactions  For The Half Year Ended On 31St March , 2022",
            "news_body": "Pursuant to Regulation 23(9) SEBI(Listing Obligations and Disclosure Requirements) Regulations,2015, please find enclosed herewith the Disclosure  of Related party Transactions of the Company  for the half year ended 31st March , 2022You are requested to please take on record the above said document for your reference and further needful.",
            "news_id": "a8d08042-5b97-42d3-a9b3-b7da83d6fc88",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a58893f9-9a2e-4283-b1b9-434480177ff0.pdf",
            "news_date": "2022-06-10 17:36:25",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Audited Financial Results For The Quarter As Well As Year Ended 31St March, 2022 In Terms Of Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are here enclosing the Audited Financial Results for the quarter as well as year ended 31st March, 2022 duly approved by the Board of Directors at its meeting held today i.e. Monday, 30th May, 2022 together with Audit Report thereon, Statement of assets and liabilities, Cash Flow Statement & declaration by the Managing Director of Company pursuant to second proviso of Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 .<BR> <BR> Further above said results shall also be submitted in XBRL mode within 24 hours from the conclusion of Board Meeting. <BR> <BR> The results shall also be uploaded on the Company''s website i.e. www.biofilgroup.net and on the website of the Stock Exchanges i.e., at www.bseindia.com & www.nseindia.com and extracts of the aforesaid results shall also be published in Hindi (Vernacular) and widely circulated English Newspaper<BR>",
            "news_id": "72bc93f9-762a-444c-9310-c45791970470",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6872a47-e567-43b3-805e-da9ca06fbe78.pdf",
            "news_date": "2022-05-30 20:21:39",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Un-Audited Financial Result For The Quarter And Nine Months Ended On 31St December, 2021 Together With Limited Review Report Thereon.",
            "news_body": "Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are hereby enclosing Un-Audited Financial Results together with Limited Review Report thereon for the quarter and nine months ended on 31st December, 2021 duly approved by the Board of Directors of the Company at its meeting held today i.e. Monday, 14th February, 2022. Copy of Unaudited Financial Results is enclosed with this letter.Further, copy of Un-Audited Financial Statements shall also be submitted in XBRL mode within 24 hours from the conclusion of Board Meeting.",
            "news_id": "3bc06dc0-2fc5-4918-862e-b56d03860c8b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58c726d4-b3e0-4825-96ec-ce8b655c18d2.pdf",
            "news_date": "2022-02-14 17:40:02",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Resubmission Of Cash Flow Statement For The Half Year Ended 30Th September, 2021 In Terms Of Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Pursuant to Regulation 33(3)(d) of SEBI(LODR) Regulations, 2015, the Un-audited Financial Statements of the Company for the Quarter and Half Year ended on 30th September, 2021 along with the Statement of Assets and Liabilities, Cash Flow Statement, Segment Reporting and Limited Review Report in the PDF Format as well as in XBRL has been submitted in the prescribed time.  <BR> <BR> Further, we would like to inform that due to typographically error of wrong entry of profit before tax and failing to enter amount of Adjustments for provisions, current in the Cash Flow Statement, PDF file was wrongly uploaded on stock exchange, however please note that there was no change in Un-audited financial results, Statement of assets & Liabilities and Segment Reporting, therefore we hereby submitting Revised Cash Flow Statement only for half year ended 30th September, 2021 after correction for your reference and records.  <BR> <BR>",
            "news_id": "ce76a6a4-ec74-4d16-bdca-645d86dd4cc5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb61d808-abe8-474c-886d-94051ff84d9c.pdf",
            "news_date": "2021-11-13 18:09:48",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Un-Audited Financial Result For The Quarter And Half Year Ended On 30Th September, 2021 In Terms Of Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are hereby enclosing Un-Audited Financial Results together with Limited Review Report thereon for the quarter and half year ended on 30th September, 2021 duly approved by the Board of Directors of the Company at its meeting held today i.e. on Friday, 12th November, 2021. <BR> <BR> Pursuant to the provisions of Regulation 33 (f) & (g) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we have also enclosed Statement of Assets and Liabilities and Cash Flow Statement for the half year ended on 30th September 2021.<BR> <BR> Further, above Un-Audited Financial Statements shall also be submitted in XBRL mode within 24 hours from the conclusion of Board Meeting.<BR> <BR> <BR>",
            "news_id": "389a9463-b634-49dc-863f-8e5eb51ec3bf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27f8cd95-f658-4e63-a7a9-cc1915e36253.pdf",
            "news_date": "2021-11-12 16:36:10",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, 12Th November, 2021 Pursuant To Regulation30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "With reference to the above captioned subject, we would like to inform that Board of Directors of the Company in their meeting held on today, i.e Friday 12th day of November 2021, has inter alia, approved the Un-audited Financial Results of the Company for the Quarter and Half year ended on 30th September, 2021 along with Segment Report, Statement of Assets and Liabilities, Cash Flow Statement and Limited Review Report thereon along with other routine businesses. Copy of results being submitted separately.<BR> <BR> The Meeting of Board of Directors commenced at 3.00 p.m. and concluded at 4.30 p.m.<BR> <BR> This is for your information and record <BR> <BR>",
            "news_id": "dde2a6ee-b578-46cf-b637-12b2d4b5abe8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a80cf618-df90-4fee-a5b6-8cbff4518ead.pdf",
            "news_date": "2021-11-12 16:32:46",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Un-Audited Financial Result Of The Company For The Quarter Ended On 30Th June, 2021 And Limited Review Report As Per Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are hereby enclosing Un-Audited Financial Results together with Limited Review Report thereon for the quarter 30th June 2021 duly approved by the Board of Directors of the Company at its meeting held today i.e. on Friday, 13th August 2021 at the Registered office of the Company. Copy of Unaudited Financial Results along with Limited Review Report is enclosed with this letter (searchable PDF mode).<BR> <BR> Further, copy of Un-Audited Financial Statements shall also be submitted in XBRL mode within 24 hours from the conclusion of Board Meeting<BR>",
            "news_id": "6b889eb6-ca72-44c6-86cb-dcd6186a8593",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83775cb4-99c0-426c-9079-04a03d802f13.pdf",
            "news_date": "2021-08-13 18:02:04",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday, 13Th August 2021 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "With reference to the above-mentioned subject and as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of the Directors of the Company in their meeting (No. 03/2021-22) held on today i.e. Friday 13th day of August 2021, following matters have been inter alia transacted along with other routine businesses:-",
            "news_id": "e4d6d91f-9660-4de5-ad61-781608f0a113",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62a91ced-cc07-4d49-8480-cafb2d51c2d6.pdf",
            "news_date": "2021-08-13 17:59:56",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure  Of Related Party Transactions  For The Half Year Ended 31St March , 2021",
            "news_body": "Pursuant to Regulation 23(9) SEBI(Listing Obligations and Disclosure Requirements) Regulations,2015, please find enclosed herewith the Disclosure  of Related party Transactions of the Company  for the half year ended 31st March , 2021",
            "news_id": "4bab225c-4113-4091-aae2-cc36fc1f1b59",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7039d0a4-b8ff-49aa-a185-d41f422830fc.pdf",
            "news_date": "2021-07-24 13:59:29",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure  Of Related Party Transactions  For The Half Year Ended 31St March , 2021",
            "news_body": "Pursuant to Regulation 23(9) SEBI(Listing Obligations and Disclosure Requirements) Regulations,2015, please find enclosed herewith the Disclosure  of Related party Transactions of the Company  for the half year ended 31st March , 2021",
            "news_id": "a04561c6-76f2-45ee-a14f-80dd88e2edfc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3c73527-d5bb-4dbd-933f-8e7637395a5d.pdf",
            "news_date": "2021-07-24 13:38:01",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Audited Financial Results For The Quarter As Well As Year Ended 31St March, 2021 In Terms Of Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to submit the Audited Financial Results for the quarter as well as year ended 31st March,2021 duly approved by the Board at its meeting held today Wednesday, 30th June, 2021 along with Audit Report thereon, Statement of assets and liabilities, Cash Flow Statement, Segment Reporting & declaration by the Managing Director of Company pursuant to second proviso of Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 .",
            "news_id": "9322aac9-135f-4275-9100-7f06f81963ea",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9efa156-7e70-4827-88da-8612b8485dd9.pdf",
            "news_date": "2021-06-30 17:24:19",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Audited Financial Results For The Quarter As Well As Year Ended 31St March, 2021 In Terms Of Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to submit the Audited Financial Results for the quarter as well as year ended 31st March,2021 duly approved by the Board at its meeting held today Wednesday, 30th June, 2021 along with Audit Report thereon, Statement of assets and liabilities, Cash Flow Statement, Segment Reporting & declaration by the Managing Director of Company pursuant to second proviso of Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 .",
            "news_id": "5e4eebb3-9716-455d-86ef-6fa36150fe29",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed005c72-0fd1-4d73-b35d-d401274afc03.pdf",
            "news_date": "2021-06-30 17:23:38",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On Wednesday 30Th June 2021 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Dear Sir/Madam,<BR> <BR> With reference to the above captioned subject, we would like to inform you that Board of Directors of the Company in their meeting (Serial No. 02/2021-22) held on today i.e., Wednesday, 30th day of June, 2021, has approved following matters along with other routine businesses <BR> 1. Approval of Audited Financial Results of the Company for the quarter as well as year ended 31st March, 2021 along with Audit Report thereon, Statement of assets and liabilities, Cash Flow Statement, Segment Reporting & declaration by the Managing Director of Company pursuant to second proviso of Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.<BR> 2. Appointment of Shri Satish Beohar  (DIN: 09220291) as an Additional Director as well as Independent Director of the Company for a term of five years from 30th June, 2021 to 29th June, 2026 subject to approval by the members at ensuing Annual General Meeting.<BR> <BR> <BR>",
            "news_id": "03a99846-0314-44b7-b857-e6548ceb4039",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f541fae0-8872-426f-9b11-cd706e574e83.pdf",
            "news_date": "2021-06-30 17:21:14",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}